News Satralizumab Shows Promise for Thyroid Eye Disease by Medscape • 2026/09/11 • 0 Comments An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show. Medscape Medical News